吸入麻醉市場（按產品、應用、最終用戶和地區）

Inhalation Anesthesia Market, By Product, By Application, By End Users, and By Geography

出版日期: 2025年05月23日 | 出版商:

Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

吸入麻醉市場規模預計在 2025 年為 14.836 億美元，預計到 2032 年將達到 21.297 億美元，2025 年至 2032 年的複合年成長率為 5.3%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	14.836億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	5.30%	2032年價值預測	21.297億美元

吸入麻醉劑（目前最常用的藥物包括氧化亞氮、氟烷、Isoflurane、DESFLURANE和SEVOFLURANE）用於在手術室誘導和維持全身麻醉。吸入麻醉劑是維持麻醉的首選，因為它們可以更精確地控制麻醉狀態，價格較低。

市場動態

慢性病盛行率上升、老年人口成長、急診病例和外科手術干預增加、吸入麻醉需求增加以及 COVID-19（大流行）的爆發是預計在預測期內促進全球吸入麻醉市場成長的關鍵因素。

例如，2022年8月，主要企業的多醫院學名藥公司Piramal Pharma Limited旗下重症加護業務宣佈在美國市場推出首個硫酸鋅注射劑非專利。該產品已獲得美國食品藥物管理局(FDA)核准為競爭性仿製學名藥。其規格有30毫克/10毫升（3毫克/毫升）和25毫克/5毫升（5毫克/毫升）。

本研究的主要特點

本報告對全球吸入麻醉市場進行了詳細分析，並提供了預測期 2025-2032 的市場規模和年複合成長率(CAGR)，假設 2024 年為基準年。
它還揭示了不同領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
該報告涵蓋了全球吸入麻醉市場的主要企業概況，基於以下參數，例如公司亮點、產品系列、主要亮點、財務表現和策略。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球吸入麻醉市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員可以透過用於分析全球吸入麻醉市場的各種策略矩陣來促進決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 1,483.6 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.30%	2032 Value Projection:	USD 2,129.7 Mn

Inhalation anesthetics (such as nitrous oxide, halothane, isoflurane, desflurane, and sevoflurane; most commonly used agents in practice today) are used for induction and maintenance of general anesthesia in the operating room. Inhaled anesthetics are preferred for maintenance of anesthesia because they allow a more precise control of the anesthetic state and do so at low cost.

Market Dynamics

Increasing prevalence of chronic disease, growing geriatric (aging) population, increasing number of emergency cases and surgical interventions, increase in demand for inhalation anesthesia, and outbreak of COVID-19 (pandemic) are major factors expected to augment the growth of the global inhalation anesthesia market during the forecast period.

For instance, in August 2022, Piramal Pharma Limited's Critical Care business, a leading Complex Hospital Generics company, announced the First to Market Generic U.S. launch of the Zinc Sulfate Injection. This product is U.S. Food and Drug Administration approved with Competitive Generic Therapy (CGT) designation; an approval pathway intended to enhance market competition for sole source drugs. The injection is available in 30mg/10mL (3mg/mL) and 25mg/5mL (5mg/mL).

Key features of the study

This report provides in-depth analysis of the global inhalation anesthesia market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global inhalation anesthesia market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Abbvie Inc., Novartis AG, Piramal Enterprises Ltd., Hikma Pharmaceuticals Plc, Fresenius SE & CO. KGaA, Halocarbon Products Corporation, Baxter International Inc., Troikaa Pharmaceuticals, Ltd., Jiangsu Hengrui Medicine Co., Ltd., Lunan Pharmaceutical Group Co. Ltd., among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global inhalation anesthesia market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhalation anesthesia market.

Detailed Segmentation

Global Inhalation Anesthesia Market, By Product
- Sevoflurane
- Desflurane
- Isoflurane
- Nitrous Oxide
Global Inhalation Anesthesia Market, By Application
- Induction
- Maintenance
Global Inhalation Anesthesia Market, By End User
- Hospitals
- Ambulatory Surgical Centers
Global Inhalation Anesthesia Market, By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles
- Abbvie Inc.
- Novartis AG
- Piramal Enterprises Ltd.
- Hikma Pharmaceuticals Plc
- Fresenius SE & CO. KgaA
- Baxter International Inc.
- Troikaa Pharmaceuticals, Ltd.
- Halocarbon Products Corporation
- Jiangsu Hengrui Medicine Co., Ltd.
- Lunan Pharmaceutical Group Co. Ltd.

Market Dynamics
- High burden of chronic disease and growing geriatric population
- Side-effects and rise in demand or adoption of generic drugs
- Increasing demand or use of novel inhalation anesthetic drugs
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Inhalation Anesthesia Market, By Product, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Sevoflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Desflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Isoflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Nitrous Oxide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

5. Global Inhalation Anesthesia Market, By Application, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Induction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Maintenance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Inhalation Anesthesia Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Inhalation Anesthesia Market, By Geography, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)

8. Competitive Landscape

Abbvie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Piramal Enterprises Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hikma Pharmaceuticals Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fresenius SE & CO. KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Troikaa Pharmaceuticals, Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Halocarbon Products Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Jiangsu Hengrui Medicine Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lunan Pharmaceutical Group Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views